2004
DOI: 10.2169/internalmedicine.43.1034
|View full text |Cite
|
Sign up to set email alerts
|

Mediastinal Pancreatic Pseudocyst Caused by Obstruction of the Pancreatic Duct Was Eliminated by Bromhexine Hydrochloride

Abstract: A 49-year-old man, who had a 30-year history of drinking the equivalent of 80 g of ethanol per day, underwent a detailed medical examination for cough and dyspnea. Chest-abdominal computed tomography and endoscopic retrograde pancreatography led to the diagnosis of a mediastinal pancreatic pseudocyst resulting from obstruction of the pancreatic duct by a protein plug. The pseudocyst rapidly improved with conservative treatment with camostat mesilate, H2-receptor antagonist and digestive enzymes. Although the p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 15 publications
0
8
0
Order By: Relevance
“…The molecular mechanism of action is unclear. In a single anecdotal case report, a mediastinal pancreatic pseudocyst due to intraluminal obstruction of the pancreatic duct was relieved by bromhexine [20].…”
Section: Bromhexinementioning
confidence: 98%
“…The molecular mechanism of action is unclear. In a single anecdotal case report, a mediastinal pancreatic pseudocyst due to intraluminal obstruction of the pancreatic duct was relieved by bromhexine [20].…”
Section: Bromhexinementioning
confidence: 98%
“…Total parenteral nutrition has also been reported to result in resolution of the cyst [7]. Successful resolution of mediastinal pseudocysts with 5-months of therapy with the mucolytic agent bromhexine hydrochloride has also been reported [8]. …”
Section: Resultsmentioning
confidence: 99%
“…Conservative treatment with strict diet, enzyme supplementation and complete abstinence from alcohol is indicated to all stable patients. In addition, bromhexine hydrochloride and somatostatin analogues have been used in a few cases [ 13 - 15 ]. Somatostatin and its analog octreotide are peptide hormones that inhibit the release of insulin, glucagon, gastrin, secretin, pancreozymin and pepsin.…”
Section: Discussionmentioning
confidence: 99%